Skip to menu Skip to content Skip to footer

Phase 1 trial of autologous Epstein-Barr virus-specific T cell therapy as treatment of progressive multiple sclerosis (2016-2017)

Experts

Emeritus Professor Michael Pender

Emeritus Professor
Royal Brisbane Clinical Unit
Faculty of Medicine
Michael Pender
Michael Pender